Currently, we are engaged in four distinct research endeavors, each outlined below:
AI-enhanced Mobile Health: Pioneering smartphone-based diagnostic technology integrated with cutting-edge artificial intelligence (AI).
POCT Diagnostics: Innovating a high-sensitivity filtration system employing bio-hybrid materials and nanofluidic functionalities.
Precision Medicine: Crafting tools for personalized medicine targeting CtDNA and exsomes, revolutionizing patient-specific treatments.
Advanced Micro & Nanosensors: Pushing boundaries in sensing technology through the application of micro/nano-scale innovations.
Our team is dedicated to advancing these areas of research and working towards developing new and innovative solutions.
Please click on the images below to connect to videos related to each topic.
현재 저희는 아래에서 설명하는 네 가지 연구를 진행 중입니다:
1.AI로 강화된 모바일 헬스: 최첨단 인공지능(AI)과 통합된 선구적인 스마트폰 기반 진단 기술.
2.현장 진단: 바이오 하이브리드 소재와 나노 유체 기능을 활용한 고감도 필터링 시스템 및 면역/분자진단 전처리 기술
3.정밀 의학: CtDNA와 엑솜을 표적으로 하는 개인 맞춤형 의학을 위한 소자 개발
4.첨단 마이크로 및 나노 센서: 마이크로/나노 스케일의 신소재 및 센싱 기술
우리 팀은 이러한 연구 분야를 발전시키고 새롭고 혁신적인 솔루션을 개발하고자합니다.
아래 이미지를 클릭하면 관련 동영상으로 연결됩니다.
We are excited to propose a groundbreaking technology that has the potential to significantly improve diagnostic capabilities through the use of AI. Our technology enables field diagnosis using only a smartphone or image analysis, without the need for external devices or equipment.
Currently, we have developed a technology that can provide highly accurate diagnosis results for COVID-19, without the use of an external cradle device. This technology outperforms even expert diagnosis accuracy. In the future, we plan to continue our research efforts to advance the field of healthcare through the development of deep learning, machine learning, and algorithms related to biodiagnosis.
Our ultimate aim is to set a major milestone in the healthcare industry by providing affordable and accessible diagnostic solutions that can benefit people all over the world. We are committed to utilizing the latest advancements in technology to drive progress and improve quality of life for all.
We are dedicated to utilizing bio-hybrid materials, devices, and systems that enable highly efficient separation and concentration of biomolecules. Our current research is focused on developing sample preparation technology capable of providing PCR-level sensitivity for on-site diagnosis. We are also exploring the potential of nanofluidic technology to develop nanoelectrokinetic pre-amplifying technology for these applications.
Our ultimate goal is to create highly efficient and effective diagnostic tools that can enhance healthcare outcomes. Through our research efforts, we strive to advance the field of bioengineering and contribute to the development of cutting-edge technologies that can be used to drive progress and innovation worldwide.
The development of highly sensitive and reliable rapid diagnostic technology is of utmost importance. Our research is currently focused on field-type diagnostic technologies that enable high sensitivity and quantitative analysis.
In addition to our diagnostic technology research, we are also developing systems that can facilitate the implementation of precision medicine. We plan to further our research in the area of diagnostic technologies such as exosomes, by combining our existing materials and AI technologies.
Our goal is to provide innovative solutions that can significantly improve diagnostic capabilities and healthcare outcomes. We believe that by leveraging the latest advancements in technology, we can drive progress and positively impact the lives of people worldwide.
micro & nano nanosensor
Our research is focused on engineering using nano/micro technology, similar to the concept of micro-nanomachines moving within the body. Specifically, we are conducting research on high-sensitivity electrical sensors that utilize external FET gates, as well as one-dimensional and two-dimensional micro/nano sensors. We are also investigating the physical phenomena related to nano/micro technologies and exploring nanosensor/process technology utilizing semiconductor technology.
Currently, we are actively researching the application of AI to the electrical and optical signals of nanosensors. Our ultimate goal is to leverage these technologies to develop innovative solutions that can improve healthcare outcomes and benefit society as a whole.
We believe that by staying at the forefront of technological advancements, we can make significant strides towards advancing the field of bioengineering.